Is roll-your-own tobacco substitute for manufactured cigarettes: evidence from Ireland?

Article English OPEN
Cornelsen, L ; Normand, C (2013)
  • Publisher: Oxford University Press (OUP)
  • Related identifiers: doi: 10.1093/pubmed/fdt030
  • Subject:
    mesheuropmc: health care economics and organizations

BACKGROUND: When tax policies increase tobacco prices some smokers may switch to smoking cheaper roll-your-own (RYO) tobacco. To reduce the harm from smoking, this substitution effect should be avoided. This study analyses whether RYO tobacco is a substitute for manufactured cigarettes (MCs) in Ireland, a country with relatively high price for both products. METHODS: Data on duty-paid consumption of RYO tobacco from 1978 to 2011 are used to estimate the demand by applying seemingly unrelated regression and error correction models. Covariates include prices of tobacco in Ireland and in the UK, income and a variable describing tobacco-related health policies. RESULTS: We failed to find evidence of RYO tobacco being a substitute for MC due to price differences. However, an increase in incomes (1%) is associated with a reduction in the consumption of RYO tobacco (-0.4%), which can be due to substitution towards MCs in addition to quitting or cutting back. Also, an increase in the price of RYO tobacco (1%) is associated with a reduction in its consumption (-1%). CONCLUSIONS: Increasing prices via taxation is an effective way of reducing the consumption of RYO tobacco but due to associations between RYO tobacco smoking and lower incomes, these policies should be accompanied by measures aimed at helping smokers to quit.
  • References (27)
    27 references, page 1 of 3

    1. Ranson MK, Jha P, Chaloupka FJ, Nguyen SN. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine & Tobacco Research. 2002; 4:311-9.

    2. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.2000.

    3. Currie L, Townsend J, Roux ML, Godfrey F, Gallus S, Gilmore A, et al. Policy Recommendations for Tobacco Taxation in the European Union. Integrated Research Findings from the PPACTE project. Dublin: The PPACTE Consortium.2012.

    4. Appel BR, Guirguis G, Kim IS, Garbin O, Fracchia M, Flessel CP, et al. Benzene, benzo(a)pyrene, and lead in smoke from tobacco products other than cigarettes. American Journal of Public Health. 1990; 80:560-4.

    5. Kaiserman MJ, Rickert WS. Handmade cigarettes: it's the tube that counts. American Journal of Public Health. 1992; 82:107-9.

    6. Kaiserman MJ, Rickert WS. Carcinogens in tobacco smoke: benzo[a]pyrene from Canadian cigarettes and cigarette tobacco. Am J Public Health. 1992; 82:1023-6.

    7. Darrall KG, Figgins JA. Roll-your-own smoke yields: theoretical and practical aspects. Tobacco Control. 1998; 7:168-75.

    8. Shahab L, West R, McNeill A. A comparison of exposure to carcinogens among rollyour-own and factory-made cigarette smokers. Addiction Biology. 2009; 14:315-20.

    9. Shahab L, West R, McNeill A. The feasibility of measuring puffing behaviour in rollyour-own cigarette smokers. Tobacco Control. 2008; 17:i17 - i23.

    10. Lewis AJ, Truman P, Hosking MR, Miller JH. Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type. Tobacco Control. 2012; 21:39-43.

  • Similar Research Results (3)
  • Metrics
    No metrics available
Share - Bookmark